Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10893713 | 0.84 | CYP3A4 (0.37) | MAPTCACNA1BAPBA1CYP3A4 | |
| SCHEMBL9547288 | 0.83 | ZDHHC20 (0.39) | ZDHHC20ZDHHC2DPP4MAPTCACNA1B | |
| SCHEMBL9547084 | 0.79 | DPP4 (0.38) | ZDHHC20ZDHHC2DPP4MAPTCACNA1B | |
| SCHEMBL9547291 | 0.76 | ZDHHC20 (0.40) | ZDHHC20ZDHHC2DPP4MAPTCYP3A4 | |
| SCHEMBL9547105 | 0.76 | DPP4 (0.37) | ZDHHC20ZDHHC2DPP4 | |
| SCHEMBL21445851 | 0.75 | DPP4 (0.39) | ZDHHC20ZDHHC2DPP4MAPTCACNA1B | |
| SCHEMBL9699061 | 0.73 | TSHR (0.32) | CYP3A4 | |
| SCHEMBL9482612 | 0.73 | CYP3A4 (0.39) | MAPTCACNA1BAPBA1CYP3A4 | |
| SCHEMBL9547259 | 0.71 | MAPT (0.36) | MAPTCACNA1BAPBA1 | |
| SCHEMBL8501214 | 0.70 | CA1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993023402-A1 | 3-AZETIDINYLTHIO-CARBAPENEME DERIVATIVES, THEIR PREPARATION AND USE AS ANTIMICROBIAL AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-11-25 | — | — | WO | disclosed |